A chondroitin sulfate purified from shark cartilage and bovine serum albumin interaction activity.

Bovine serum albumin Chondroitin sulfate Fluorescence quenching Molecular docking

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 30 10 2023
revised: 31 12 2023
accepted: 12 01 2024
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 23 1 2024
Statut: aheadofprint

Résumé

Chondroitin sulfate (CS) was extracted and purified from shark cartilage, and its interaction with bovine serum albumin (BSA) were studied. The content of chondroitin sulfate in shark cartilage was 29.97 % using the 1,9-dimethyl-methylene blue method. The molecular weight of CS was determined to be 62.464 kDa by high-performance gel permeation chromatography. UV and FT-IR spectroscopy identified the characteristics of CS and its functional group information. NMR spectroscopy and disaccharide derivatization revealed that CS was predominantly composed of disulfated disaccharides, specifically ΔDi4,6S. Fluorescence quenching experiments indicated that the interaction between CS and BSA exhibited static quenching, with a binding site number of 1. The binding process was primarily mediated by van der Waals forces and hydrogen bonds. Furthermore, synchronous and 3D fluorescence spectroscopy demonstrated that CS had minimal impact on the polarity and hydrophobicity of the microenvironment surrounding Tyr and Trp residues. UV-vis absorption and circular dichroism (CD) spectroscopy demonstrated the altered structure of BSA. The molecular docking analysis revealed that CS formed hydrogen bonds and salt bridges with BSA, predominantly binding to the IIA substructure domain of BSA. Investigating the interaction between CS and BSA holds the potential for enhancing its applications in drug delivery and tissue engineering endeavors.

Identifiants

pubmed: 38262829
pii: S0141-8130(24)00302-7
doi: 10.1016/j.ijbiomac.2024.129499
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129499

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The materials discussed herein have not been published elsewhere before, and the manuscript has not been submitted to any other journals.

Auteurs

Hai-Long Pang (HL)

Department of Pharmacy, Weifang Medical University, Weifang, Shandong, China; Department of Pharmacy, Jining Medical University, Rizhao, Shandong, China.

Han Lu (H)

Department of Pharmacy, Weifang Medical University, Weifang, Shandong, China; Department of Pharmacy, Jining Medical University, Rizhao, Shandong, China.

Peng Liu (P)

Rizhao Science and Technology Innovation Service Center, Rizhao, Shandong, China.

Yun-Tao Zhang (YT)

Department of Pharmacy, Jining Medical University, Rizhao, Shandong, China. Electronic address: zhangyt@mail.jnmc.edu.cn.

Li-Tao Zhang (LT)

Department of Biological Science, Jining Medical University, Rizhao, Shandong, China. Electronic address: zhanglitao@mail.jnmc.edu.cn.

Qiang Ren (Q)

Department of Pharmacy, Jining Medical University, Rizhao, Shandong, China. Electronic address: renqiang@mail.jnmc.edu.cn.

Classifications MeSH